{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:10:53Z","timestamp":1792714253627,"version":"4.5.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01188","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T04:52:39Z","timestamp":1592369559000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases"],"prefix":"10.3389","volume":"11","author":[{"given":"Livia Sophie","family":"Hofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Ramberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Gredler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sophie","family":"Pescoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Rost\u00e1sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Sospedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Lutterotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/glia.1111","article-title":"T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"36","author":"Iglesias","year":"2001","journal-title":"Glia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1212\/NXI.0000000000000062","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J Neuroinflammation."},{"key":"B8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/jamaneurol.2018.1055","article-title":"Anti-myelin oligodendrocyte glycoprotein antibody-associated central nervous system demyelination-a novel disease entity?","volume":"75","author":"Weber","year":"2018","journal-title":"JAMA Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/2051-5960-1-85","article-title":"T cell-activation in neuromyelitis optica lesions plays a role in their formation","volume":"1","author":"Pohl","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00401-018-1950-8","article-title":"Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat","volume":"137","author":"Hillebrand","year":"2019","journal-title":"Acta Neuropathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12123","DOI":"10.1074\/jbc.M115.647149","article-title":"Mutagenesis of the aquaporin 4 extracellular domains defines restricted binding patterns of pathogenic neuromyelitis optica IgG","volume":"290","author":"Owens","year":"2015","journal-title":"J Biol Chem"},{"key":"B15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12974-016-0642-3","article-title":"Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders","volume":"13","author":"Tuller","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-2094-7-52","article-title":"Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance","volume":"7","author":"Jarius","year":"2010","journal-title":"J Neuroinflammation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.clim.2010.11.013","article-title":"Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases","volume":"138","author":"Di Pauli","year":"2011","journal-title":"Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"108","author":"Chihara","year":"2011","journal-title":"PNAS"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/brain\/awy010","article-title":"Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica","volume":"141","author":"Wilson","year":"2018","journal-title":"Brain"},{"key":"B21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00401-011-0824-0","article-title":"Pathogenic T cell responses against aquaporin 4","volume":"122","author":"Pohl","year":"2011","journal-title":"Acta Neuropathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00401-015-1501-5","article-title":"Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS","volume":"130","author":"Zeka","year":"2015","journal-title":"Acta Neuropathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/WCO.0000000000000551","article-title":"Mechanisms for lesion localization in neuromyelitis optica spectrum disorders","volume":"31","author":"Bradl","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00401-013-1116-7","article-title":"Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica","volume":"125","author":"Misu","year":"2013","journal-title":"Acta Neuropathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica","volume":"24","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-015-0207-1","article-title":"Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica","volume":"3","author":"Jones","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s00415-009-5274-4","article-title":"Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis","volume":"256","author":"Uzawa","year":"2009","journal-title":"J Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jocn.2011.01.031","article-title":"Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse","volume":"18","author":"Wang","year":"2011","journal-title":"J Clin Neurosci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ana.23651","article-title":"Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter","volume":"72","author":"Varrin-Doyer","year":"2012","journal-title":"Ann Neurol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10875-012-9780-2","article-title":"The ex vivo production of IL-6 and IL-21 by CD4+ T cells is directly associated with neurological disability in neuromyelitis optica patients","volume":"33","author":"Linhares","year":"2013","journal-title":"J Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/cei.12733","article-title":"Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase","volume":"183","author":"Barros","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2055217319848463","DOI":"10.1177\/2055217319848463","article-title":"Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases","volume":"5","author":"Hofer","year":"2019","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"B35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jaut.2011.01.004","article-title":"Fine specificity of antibodies against AQP4: epitope mapping reveals intracellular epitopes","volume":"36","author":"Kampylafka","year":"2011","journal-title":"J Autoimmun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/intimm\/dxr056","article-title":"Increased T-cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica","volume":"23","author":"Matsuya","year":"2011","journal-title":"Int Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1001\/archneurol.2012.1300","article-title":"Human aquaporin 4281-300 is the immunodominant linear determinant in the context of HLA-DRB1*03:01: relevance for diagnosing and monitoring patients with neuromyelitis optica","volume":"69","author":"Arellano","year":"2012","journal-title":"Arch Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.msard.2015.12.004","article-title":"T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO)","volume":"6","author":"Vaknin-Dembinsky","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.4049\/jimmunol.172.6.3893","article-title":"Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis","volume":"172","author":"Bielekova","year":"2004","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.clim.2012.12.008","article-title":"Increased Th17 response to myelin peptides in pediatric MS","volume":"146","author":"Vargas-Lowy","year":"2013","journal-title":"Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1212\/NXI.0000000000000020","article-title":"MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS","volume":"1","author":"Varrin-Doyer","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B42","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/eji.1830250419","article-title":"Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL\/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes","volume":"25","author":"Kerlero de Rosbo","year":"1995","journal-title":"Eur J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1212\/NXI.0000000000000022","article-title":"Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE","volume":"1","author":"Shetty","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fimmu.2017.00529","article-title":"Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases","volume":"8","author":"Peschl","year":"2017","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2017","journal-title":"Lancet Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e10455","DOI":"10.1371\/journal.pone.0010455","article-title":"Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica","volume":"5","author":"Mader","year":"2010","journal-title":"PLoS ONE"},{"key":"B48","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","article-title":"Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome","volume":"89","author":"Hennes","year":"2017","journal-title":"Neurology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1212\/NXI.0000000000000674","article-title":"International multicenter examination of MOG antibody assays","volume":"7","author":"Reindl","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/cells1030313","article-title":"Optimal thawing of cryopreserved peripheral blood mononuclear cells for use in high-throughput human immune monitoring studies","volume":"1","author":"Ramachandran","year":"2012","journal-title":"Cells"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e16083","DOI":"10.1371\/journal.pone.0016083","article-title":"Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica","volume":"6","author":"Kalluri","year":"2011","journal-title":"PLoS ONE"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1002\/eji.1830271144","article-title":"Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions","volume":"27","author":"Kerlero de Rosbo","year":"1997","journal-title":"Eur J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7119","DOI":"10.4049\/jimmunol.167.12.7119","article-title":"T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells","volume":"167","author":"Forsthuber","year":"2001","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.4049\/jimmunol.179.8.5090","article-title":"CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice","volume":"179","author":"Mars","year":"2007","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"548","DOI":"10.4049\/jimmunol.169.1.548","article-title":"High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes","volume":"169","author":"Weissert","year":"2002","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e15050","DOI":"10.1371\/journal.pone.0015050","article-title":"Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica","volume":"5","author":"Nelson","year":"2010","journal-title":"PLoS ONE"},{"key":"B57","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1056\/NEJMe1906559","article-title":"New guidelines for statistical reporting in the journal","volume":"381","author":"Harrington","year":"2019","journal-title":"N Engl J Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"9216","DOI":"10.1074\/jbc.M110.123000","article-title":"Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding","volume":"286","author":"Pisani","year":"2011","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"30578","DOI":"10.1074\/jbc.M114.582221","article-title":"Identification of a point mutation impairing the binding between aquaporin-4 and neuromyelitis optica autoantibodies","volume":"289","author":"Pisani","year":"2014","journal-title":"J Biol Chem"},{"key":"B60","doi-asserted-by":"publisher","first-page":"8460","DOI":"10.1073\/pnas.1820039116","article-title":"Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial","volume":"116","author":"Zubizarreta","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B61","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1399-0039.2008.01172.x","article-title":"Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders","volume":"73","author":"Matsushita","year":"2009","journal-title":"Tissue Antigens"},{"key":"B62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/1352458509350741","article-title":"HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis","volume":"16","author":"Brum","year":"2010","journal-title":"Mult Scler"},{"key":"B63","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/1352458510382810","article-title":"Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population","volume":"17","author":"Deschamps","year":"2011","journal-title":"Mult Scler"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1212\/NXI.0000000000000204","article-title":"Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis","volume":"3","author":"Metz","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B65","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1172\/JCI15861","article-title":"Myelin\/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice","volume":"112","author":"Delarasse","year":"2003","journal-title":"J Clin Invest"},{"key":"B67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4161\/chan.3735","article-title":"Distribution of the AQP4 water channel in normal human tissues: protein and tissue microarrays reveal expression in several new anatomical locations, including the prostate gland and seminal vesicles","volume":"1","author":"Mobasheri","year":"2007","journal-title":"Channels."},{"key":"B68","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/bpa.12085","article-title":"Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO","volume":"23","author":"Verkman","year":"2013","journal-title":"Brain Pathol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"14781","DOI":"10.1073\/pnas.1617859114","article-title":"Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4","volume":"113","author":"Sagan","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B70","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/eji.201646855","article-title":"Deletional tolerance prevents AQP4-directed autoimmunity in mice","volume":"47","author":"Vogel","year":"2017","journal-title":"Eur J Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1471-4159.1999.0720001.x","article-title":"The structure and function of myelin oligodendrocyte glycoprotein","volume":"72","author":"Johns","year":"1999","journal-title":"J Neurochem"},{"key":"B72","doi-asserted-by":"publisher","first-page":"151427","DOI":"10.1155\/2013\/151427","article-title":"Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis","volume":"2013","author":"Greer","year":"2013","journal-title":"Mult Scler Int"},{"key":"B73","doi-asserted-by":"publisher","first-page":"6720","DOI":"10.4049\/jimmunol.166.11.6720","article-title":"Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions","volume":"166","author":"Godkin","year":"2001","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1073\/pnas.1519608113","article-title":"Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease","volume":"113","author":"Flach","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B75","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00401-016-1559-8","article-title":"Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen","volume":"132","author":"Kinzel","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.25291","article-title":"Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein","volume":"84","author":"Spadaro","year":"2018","journal-title":"Ann Neurol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaut.2019.04.013","article-title":"Myelin oligodendrocyte glycoprotein revisited-sensitive detection of MOG-specific T-cells in multiple sclerosis","volume":"102","author":"Bronge","year":"2019","journal-title":"J Autoimmun"},{"key":"B78","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann Neurol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"188ra175","DOI":"10.1126\/scitranslmed.3006168","article-title":"Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis","volume":"5","author":"Lutterotti","year":"2013","journal-title":"Sci Transl Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S1046-2023(02)00346-8","article-title":"Use of combinatorial peptide libraries for T-cell epitope mapping","volume":"29","author":"Sospedra","year":"2003","journal-title":"Methods"},{"key":"B81","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jim.2003.09.004","article-title":"A sensitive method for detecting proliferation of rare autoantigen-specific human T cells","volume":"283","author":"Mannering","year":"2003","journal-title":"J Immunol Methods"},{"key":"B82","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0022-1759(87)90131-1","article-title":"Improvement of the in vitro T cell proliferation assay by a modified method that separates the antigen recognition and IL-2-dependent steps","volume":"99","author":"Chain","year":"1987","journal-title":"J Immunol Methods"},{"key":"B83","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1186\/1756-0500-7-662","article-title":"Proliferation assay amplification by IL-2 in model primary and recall antigen systems","volume":"7","author":"Kennell","year":"2014","journal-title":"BMC Res Notes"},{"key":"B84","doi-asserted-by":"publisher","first-page":"zsw070","DOI":"10.1093\/sleep\/zsw070","article-title":"CD4+ T-cell reactivity to orexin\/hypocretin in patients with narcolepsy type 1","volume":"40","author":"Ramberger","year":"2017","journal-title":"Sleep"},{"key":"B85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-60327-527-9_6","article-title":"Generation of human T cell clones","volume":"514","author":"Mariotti","year":"2009","journal-title":"Methods Mol Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01188\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T04:52:41Z","timestamp":1592369561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01188\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":85,"alternative-id":["10.3389\/fimmu.2020.01188"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01188","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"article-number":"1188"}}